|
⚲
|
| Tapimmune Inc | |
|---|---|
| Firm | |
| Fund # | |
| CIK # | 0001094038 |
| Sale | 2009-09-28 ($0.7 M Offered, $0.7 M Sold) |
| Fund | |
| Phone | 4254622556 |
| Address | 800 Bellevue Way, Ne, Suite 400 Bellevue, 98004 |
| Source | [EDGAR] |
| Fund AUM and Sold ($k) |
|---|
| Fund Details | |
|---|---|
| Director | |
| Custodian | |
| Auditor | |
| Marketer | |
| Broker | |
| Jurisdiction |
| Directors | 2011 - 2025 |
|---|---|
| Glynn Wilson | |
| Denis Corin | |
| Tracy Moore |
| Comparable Firms | State | AUM ($B) |
|---|---|---|
|
Auxilium Pharmaceuticals Inc
✚
|
0.0 | |
|
Auxogyn, Inc.
✚
|
0.0 | |
|
Avalon Theatrical Partners, Ltd Liability Co
✚
|
0.0 | |
|
Avangard Innovative Technologies Inc.
✚
|
0.0 | |
|
Aventia (US) Fund
✚
|
0.0 | |
|
Avery Nathan M
✚
|
0.0 | |
|
Avery Partners LLC
✚
|
0.0 | |
|
Avesta Platform Partners LLC
✚
|
0.0 | |
|
Avistone Gateway, LLC
✚
|
0.0 | |
|
Newquant Capital Inc
✚
|
0.0 |